IL240019A0 - Estrogen receptor inhibitors - Google Patents

Estrogen receptor inhibitors

Info

Publication number
IL240019A0
IL240019A0 IL240019A IL24001915A IL240019A0 IL 240019 A0 IL240019 A0 IL 240019A0 IL 240019 A IL240019 A IL 240019A IL 24001915 A IL24001915 A IL 24001915A IL 240019 A0 IL240019 A0 IL 240019A0
Authority
IL
Israel
Prior art keywords
estrogen receptor
receptor inhibitors
inhibitors
estrogen
receptor
Prior art date
Application number
IL240019A
Other languages
English (en)
Hebrew (he)
Original Assignee
David J Shapiro
Neal D Andruska
Mathew M Cherian
Lily Mahapatra
Mao Chengjian
William Helferich
Xujuan Yang
Xiaobin Zheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David J Shapiro, Neal D Andruska, Mathew M Cherian, Lily Mahapatra, Mao Chengjian, William Helferich, Xujuan Yang, Xiaobin Zheng filed Critical David J Shapiro
Publication of IL240019A0 publication Critical patent/IL240019A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL240019A 2013-01-18 2015-07-19 Estrogen receptor inhibitors IL240019A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361754292P 2013-01-18 2013-01-18
PCT/US2014/012405 WO2014113820A1 (fr) 2013-01-18 2014-01-21 Inhibiteurs d'un récepteur des œstrogènes

Publications (1)

Publication Number Publication Date
IL240019A0 true IL240019A0 (en) 2015-09-24

Family

ID=51210145

Family Applications (1)

Application Number Title Priority Date Filing Date
IL240019A IL240019A0 (en) 2013-01-18 2015-07-19 Estrogen receptor inhibitors

Country Status (5)

Country Link
EP (1) EP2945646A4 (fr)
AU (1) AU2014207272A1 (fr)
CA (1) CA2898732A1 (fr)
IL (1) IL240019A0 (fr)
WO (1) WO2014113820A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107164519A (zh) * 2017-06-26 2017-09-15 深圳优圣康医学检验所有限公司 一种基于荧光pcr检测esr1基因突变的引物及探针
PE20210662A1 (es) * 2018-07-03 2021-03-31 Univ Illinois Activadores de la respuesta a proteinas desplegadas
WO2021222738A1 (fr) * 2020-05-01 2021-11-04 The Board Of Trustees Of The University Of Illinois Composés pour cancers positifs au récepteur des oestrogènes
WO2022032146A1 (fr) * 2020-08-07 2022-02-10 Systems Oncology, Llc Procédés d'inhibition de la croissance de cancers era positifs
CN113237860A (zh) * 2021-05-17 2021-08-10 丹望医疗科技(上海)有限公司 检测类器官最大截面积的方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES426436A1 (es) * 1974-05-18 1976-07-01 Andreu Sa Dr Procedimiento para la obtencion de derivados de la 3,3-bis (4-hidroxifenil)-2-indolinona.
CA2022356A1 (fr) * 1990-07-31 1992-02-01 David J. Shapiro Methode et matieres pour la production de proteines
AU2005214338B2 (en) * 2004-02-13 2011-11-10 President And Fellows Of Harvard College 3-3-di-substituted-oxindoles as inhibitors of translation initiation
KR20060130781A (ko) * 2004-04-08 2006-12-19 토포타겟 에이/에스 다이페닐 인돌-2-온 화합물 및 암 치료에 있어서의 그의용도
EP2488027A4 (fr) * 2009-10-09 2013-04-17 Univ Ohio State Res Found Agents mimétiques de restriction énergétique de thiazolidinédione

Also Published As

Publication number Publication date
EP2945646A4 (fr) 2016-09-21
EP2945646A1 (fr) 2015-11-25
CA2898732A1 (fr) 2014-07-24
WO2014113820A1 (fr) 2014-07-24
AU2014207272A1 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
HK1221826A1 (zh) 用於覆蓋受限設備的覆蓋擴展水平
HK1222282A1 (zh) 用於覆蓋有限設備的覆蓋擴展水平
HK1216531A1 (zh) 新的抑制劑
EP2975600A4 (fr) Dispositif de fixation
EP2988582A4 (fr) Dispositif de serrage de substrat
IL240019A0 (en) Estrogen receptor inhibitors
GB201313126D0 (en) MOS-Bipolar Device
EP2947000A4 (fr) Dispositif d'ancrage pour aérostats
PT3051152T (pt) Estrutura de ligação para peças de madeira
HUE037305T2 (hu) Elosztó berendezés
GB201310610D0 (en) Object-handling device
GB201303718D0 (en) Device
HK1218647A1 (zh) 血管加壓素- 受體激動劑
GB201312493D0 (en) Stopperr device
GB201307466D0 (en) Device
GB201312010D0 (en) Receptor Agonists
TWM475903U (en) Device for praying
GB201311454D0 (en) Envelope-outlining device
HK1217700A1 (zh) 多晶型物形式
GB201304666D0 (en) Dopamine receptor antagonist
GB201301896D0 (en) Novel Estrogen Receptor Ligands
GB201304105D0 (en) Agonist
GB201319790D0 (en) Device for framing
GB201319680D0 (en) An indirect calorimeter
GB201312359D0 (en) Device tracability